Skip to main content
Lee Cranmer, MD, Oncology, Seattle, WA

LeeDCranmerMD

Oncology Seattle, WA

Physician

Dr. Cranmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cranmer's full profile

Already have an account?

  • Office

    825 Eastlake Ave E
    Seattle, WA 98109
    Phone+1 206-288-1000

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2001 - 2003
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1998 - 2001
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 1998

Certifications & Licensure

  • AK State Medical License
    AK State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2024 - 2026
  • WA State Medical License
    WA State Medical License 2015 - 2026
  • ID State Medical License
    ID State Medical License 2023 - 2025
  • OR State Medical License
    OR State Medical License 2021 - 2025
  • AZ State Medical License
    AZ State Medical License 2001 - 2016
  • MN State Medical License
    MN State Medical License 1999 - 2001

Publications & Presentations

PubMed

Press Mentions

  • Fred Hutch at AACR: New Targets for Cancer Therapies, Experts Available in Diversity and Cancer Screening Tests — and Fred Hutch’s Philip Greenberg Becomes AACR President
    Fred Hutch at AACR: New Targets for Cancer Therapies, Experts Available in Diversity and Cancer Screening Tests — and Fred Hutch’s Philip Greenberg Becomes AACR PresidentApril 6th, 2023
  • Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study
    Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical StudyApril 6th, 2023
  • Tip Sheet: New Combination Drug for Respiratory Viruses, Treatments for Peripheral Neuropathy – and AACR 2023
    Tip Sheet: New Combination Drug for Respiratory Viruses, Treatments for Peripheral Neuropathy – and AACR 2023April 4th, 2023
  • Join now to see all

Professional Memberships